Cargando…
No changes in hemostasis after COVID-19–heterologous vaccination schedule: A subanalysis of the phase 2 CombiVacS study
BACKGROUND: Several cases of unusual thrombotic events and thrombocytopenia were described after vaccination with recombinant adenoviral vectors encoding the spike protein antigen of SARS-CoV-2. OBJECTIVES: The objective of this study was to elucidate the impact of a COVID-19 heterologous vaccinatio...
Autores principales: | Butta, Nora V., Arias-Salgado, Elena G., Monzón Manzano, Elena, Acuña, Paula, Álvarez Román, María Teresa, Buño-Soto, Antonio, Ramos Ramos, Juan Carlos, Belda-Iniesta, Cristóbal, Frías, Jesús, Carcas, Antonio J., de Soto, Lucía Martínez, de Miguel Buckley, Rosa, Lora, David, García-Morales, María Teresa, Borobia, Alberto M., Arribas, José Ramón, Jiménez Yuste, Víctor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840220/ https://www.ncbi.nlm.nih.gov/pubmed/36685004 http://dx.doi.org/10.1016/j.rpth.2023.100049 |
Ejemplares similares
-
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial
por: Borobia, Alberto M, et al.
Publicado: (2021) -
Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study
por: García-Pérez, Javier, et al.
Publicado: (2022) -
Health Care Workers’ Reasons for Choosing Between Two Different COVID-19 Prophylaxis Trials in an Acute Pandemic Context: Single-Center Questionnaire Study
por: Borobia, Alberto M, et al.
Publicado: (2021) -
Consultor Combi visual
Publicado: (1992) -
Consultor Combi visual
Publicado: (1988)